As the race to develop a COVID-19 vaccine continues at speed, the world faces many more questions than answers – not only about when we might have a vaccine, but who will get it first, how will they get it and are they willing to have it? And how far will it take us on the journey back to ‘normal’…?
Ipsos today publishes the seventh edition of its Future Risks Report for Axa. This global study measures and ranks changes in the perception of emerging risks by a panel of risk management experts and the general public. Over 20,000 people were interviewed. Conducted in partnership with research institute Ipsos and geopolitical analysis consultancy Eurasia Group, this year’s ranking of the 10 main emerging risks is marked by the Covid-19 crisis.
In a COVID-19 world, companies that can balance sustainability, hygiene and value will build long-term reputational equity and greater chance of success.
